Olmesartán/Amlodipino/Hidroclorotiazida Lacer (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxil, amlodipine, hydrochlorothiazide, the active ingredient in Olmesartán/Amlodipino/Hidroclorotiazida Lacer, is a combination antihypertensive presented as a tablet for oral use. It treats high blood pressure and related cardiovascular risk in adult patients. GNH USA supplies Olmesartán/Amlodipino/Hidroclorotiazida Lacer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmesartán/Amlodipino/Hidroclorotiazida Lacer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan/Amlodipine/Hydrochlorothiazide is used in the management of hypertension, a condition characterized by elevated arterial pressure.

- Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Hypertensive heart disease: helps prevent progression of left‑ventricular hypertrophy. - Chronic kidney disease with hypertension: assists in slowing renal function decline associated with high blood pressure. - Stroke prevention: contributes to reduced incidence of stroke in high‑risk hypertensive patients. - Diabetes‑related hypertension: aids  as a component of multifactorial blood‑pressure control in diabetic patients.

Common Side Effects: - Dizziness   -             ...    …    ... ...  ....  ...  ...  …  … ...  … … 

Serious or Rare Side Effects: -          ...    …  ... effects     t   t  t \

Olmesartan/Amlodipine   g   t \